Studies have reported that tacrolimus can reduce insulin secretion and insulin receptor expression by inducing pancreatic cell apoptosis, thereby increasing insulin resistance and plasma glucose concentrations to cause diabetes (78). Here, INS is linked to Insulin resistance.